SalaryGuide
AboutPricingBlogFor Employers

Marketing jobs

11 marketing jobs

Galderma logo
1 day ago

Senior Manager, Corporate Communications

Galderma

Boston, MA (On-site)Full time$148K/yr – $185K/yr
Galderma logo
5 days ago

National Key Thought Leader Engagement - Marketing

Galderma

Florida, USA (On-site)Full time$175K/yr – $205K/yr
Galderma logo
8 days ago

Director, Portfolio Growth Marketing

Galderma

Florida, USA (On-site)Full time$196K/yr – $246K/yr
Galderma logo
4 weeks ago

Brand Manager, Toxins

Galderma

Florida, USA (On-site)Full time$125K/yr – $160K/yr
Galderma logo
4 weeks ago

Brand Manager, Fillers

Galderma

Florida, USA (On-site)Full time$125K/yr – $160K/yr
Galderma logo
4 weeks ago

Thought Leader Marketing Liaison

Galderma

Chicago, IL (Hybrid)Full time$190K/yr – $230K/yr
Galderma logo
5 weeks ago

Manager, Digital Content & Creator Marketing

Galderma

USA (Unknown)Full time$125K/yr – $160K/yr
Galderma logo
5 weeks ago

Manager, Digital Content & Creator Marketing

Galderma

Florida, USA (On-site)Full time$125K/yr – $160K/yr
Galderma logo
6 weeks ago

Thought Leader Marketing Liaison - Remote (Southeast)

Galderma

Miami, FL (Remote)Full time$185K/yr – $225K/yr
Galderma logo
6 months ago

Senior Manager, Regional Field Marketing - Aesthetics (Central)

Galderma

Denver, CO (Remote)Full time$140K/yr – $175K/yr
Galderma logo
6 months ago

Director of Media Marketing Strategy and Optimization

Galderma

Boston, MA (On-site)Other$225K/yr – $265K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

11 jobs
Galderma logo

Senior Manager, Corporate Communications

Galderma

Boston, MA (On-site)

$148K/yr - $185K/yrIn-houseFull-timeSenior level
1 day ago
Galderma logo

National Key Thought Leader Engagement - Marketing

Galderma

Florida, USA (On-site)

$175K/yr - $205K/yrIn-houseFull-timeSenior level8+ years exp.
5 days ago
Galderma logo

Director, Portfolio Growth Marketing

Galderma

Florida, USA (On-site)

$196K/yr - $246K/yrIn-houseFull-timeDirector/executive8+ years exp.
8 days ago
Galderma logo

Brand Manager, Toxins

Galderma

Florida, USA (On-site)

$125K/yr - $160K/yrIn-houseFull-timeMid level5+ years exp.
4 weeks ago
Galderma logo

Brand Manager, Fillers

Galderma

Florida, USA (On-site)

$125K/yr - $160K/yrIn-houseFull-timeSenior level5+ years exp.
4 weeks ago
Galderma logo

Thought Leader Marketing Liaison

Galderma

Chicago, IL (Hybrid)

$190K/yr - $230K/yrIn-houseFull-timeSenior level7+ years exp.
4 weeks ago
Galderma logo

Manager, Digital Content & Creator Marketing

Galderma

USA (Unknown)

$125K/yr - $160K/yrIn-houseFull-timeManager6+ years exp.
5 weeks ago
Galderma logo

Manager, Digital Content & Creator Marketing

Galderma

Florida, USA (On-site)

$125K/yr - $160K/yrIn-houseFull-timeManager6+ years exp.
5 weeks ago
Galderma logo

Thought Leader Marketing Liaison - Remote (Southeast)

Galderma

Miami, FL (Remote)

$185K/yr - $225K/yrIn-houseFull-timeSenior level7+ years exp.
6 weeks ago
Galderma logo

Senior Manager, Regional Field Marketing - Aesthetics (Central)

Galderma

Denver, CO (Remote)

$140K/yr - $175K/yrIn-houseFull-timeSenior level8+ years exp.
6 months ago
Galderma logo

Director of Media Marketing Strategy and Optimization

Galderma

Boston, MA (On-site)

$225K/yr - $265K/yrIn-houseOtherSenior level8+ years exp.
6 months ago
Galderma logo
Galderma

Senior Manager, Corporate Communications

Boston, MA (On-site)

$148K/yr – $185K/yrSenior LevelFull time

Posted 1 day ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Own and execute the U.S. corporate communications strategy, lead media relations and executive visibility, and manage internal and social channels to support growth milestones.

  • Develop external messaging and press materials to elevate external profile
  • Oversee social and internal communications to align with growth milestones

Job Description

Responsibilities

  • Lead the development and execution of a U.S. corporate communications strategy that elevates Galderma’s external profile and reinforces our leadership in dermatology.
  • Partner closely with our corporate communications agency to shape and activate proactive earned media, corporate announcements, and reputation-building initiatives.
  • Develop external messaging, press materials, corporate positioning, and executive visibility plans.
  • Support media engagement, conference visibility, and corporate storytelling aligned with key U.S. priorities and growth milestones.
  • Manage and enhance the U.S. social media strategy across corporate channels — including content development, editorial planning, and publishing for U.S. LinkedIn.
  • Own internal communications strategy to strengthen alignment, transparency, and engagement across all levels of the organization.
  • Lead U.S. internal communications strategy to strengthen alignment, transparency, and engagement across all levels of the organization.
  • Own key internal channels including Town Halls, leadership updates, newsletters, employee announcements, and enterprise-wide communication moments.

Benefits

  • Galderma offers a competitive and comprehensive benefits program, including medical, dental, and vision coverage, a 401(k) plan with employer match, paid time off, and other benefits, subject to eligibility and applicable plan terms.
Galderma logo

Galderma

3.5 Glassdoor

Galderma is the leading company solely dedicated to skin and advancing the future of dermatology.We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.

Founded in 1981
Zug, Zug, CHE
8.4K employees (842 in marketing)
www.galderma.com
60% recommend to a friend
62% CEO approval

Salaries

Posted range

$148K/yr – $185K/yr

Taken straight from the job posting.

See all Galderma salaries

Marketing Team

Marketing Team Size
722 (9% of company)
Median Career Experience
18 years
Median Tenure
4.5 years
Marketing Roles Posted (Last 30 Days)
5

People

Marketing Leadership

Crystal Cienfuegos Muilenburg
Crystal Cienfuegos Muilenburg
Vice President, Aesthetics Marketing
At the company for 1 year 3 months
Jessica Coppola
Jessica Coppola
Vice President of Marketing, Therapeutic Dermatology ad interim
At the company for 4 years 6 months
Alicia Criner
Alicia Criner
Vice President, Global Head of Marketing and Digital, Galderma (Skincare, Aesthetics, Prescription)
At the company for 5 years 9 months
Jen Brown
Jen Brown
Senior Director, Head of HCP Marketing Immunology
At the company for 3 years 6 months

Funding

Total Funding
$9.3B
Last Raise
$4.8B
Post IPO Secondary, 3 months ago

Funding History

  • Dec 2025
    Post IPO Secondary • $4.8B
  • Nov 2025
    Post IPO Debt • $220.2M
  • Jul 2025
    Post IPO Secondary • $2.6B

Traffic Signals

Monthly Visitors
187.4K
Traffic Source Mix
Search
52.4%
Direct
34.7%
Referral
9.4%
Social
2.5%
Paid
0.9%

Headcount Trend

Current headcount: ~8.4K

Recent News

UBS stuft Galderma hoch - Aktienkurs vor neuem Allzeithoch
Nov 25, 2025 • cash.ch
UBS vergibt höchstes Kursziel für Galderma - Aktie auf neuem Allzeithoch
Nov 25, 2025 • cash.ch
Starke Sculptra-Performance: UBS stuft Galderma-Aktie auf ’Buy’ hoch
Nov 25, 2025 • Investing.com Deutsch
Börsen-Ticker: Schweizer Aktienmarkt unentschlossen - Galderma auf Allzeithoch - Amrize führt SMI an - medmix steigt, Idorsia fällt - Stimmung bleibt angeschlagen
Nov 25, 2025 • cash.ch
Verändern die neuen Restylane Lyft-Daten und die FDA-Zulassung den Wettbewerbsvorteil von Galderma (SWX:GALD)?
Nov 20, 2025 • simplywall.st
Galderma-Aktie schwächelt: Neue Daten zu Restylane und Sculptra auf Fachtagung
Nov 17, 2025 • Finanzen.ch
Galderma zeigt neue Daten an Fachtagung
Nov 17, 2025 • cash.ch
Galderma schließt Anleiheemission über 175 Millionen Franken ab
Nov 14, 2025 • MarketScreener Deutschland
Sollte die neue FDA-Zulassung von Restylane Lyft die Wachstumserwartungen für die Galderma Group (SWX:GALD) verändern?
Nov 12, 2025 • simplywall.st
Galderma erhält US-FDA-Zulassung für Restylane Lyft zur Kinnaugmentation
Nov 5, 2025 • MarketScreener Schweiz
Galderma erhält US-Zulassung für Restylane Lyft zur Kinnbehandlung
Nov 5, 2025 • cash.ch
Restylane Lyft: Galderma erhält US-Zulassung für Injektionsgel zur Kinnbehandlung
Nov 5, 2025 • Finanz und Wirtschaft
Warum die Galderma-Gruppe (SWX:GALD) nach der Anhebung der Umsatzwachstumsprognose für 2025 um 5,6% steigt
Oct 30, 2025 • simplywall.st
EQT-Fonds schließt Platzierung von Galderma Group-Aktien ab
Oct 30, 2025 • MarketScreener Schweiz
EQT und Partner veräußern weitere Aktienpakete an Galderma
Oct 28, 2025 • MarketScreener Deutschland
Galderma-Anteilseigner nutzen Kursrally für Milliardenverkauf
Oct 28, 2025 • Bloomberg.com
Beteiligungsfirma verkauft Galderma-Aktien im Wert von 2,6 Milliarden Franken – Anleger bleiben gelassen
Oct 28, 2025 • cash.ch
Galderma: Sekundäres ABO-Block-Trade-Angebot umfasst rund 20 Millionen Aktien
Oct 27, 2025 • MarketScreener Schweiz
Galderma: Bücher der sekundären ABB-Transaktion abgedeckt, so der Bookrunner
Oct 27, 2025 • MarketScreener Schweiz
FuW-Analyse zu den Umsatzzahlen: Galdermas Umsatzzahlen sind eine Augenweide
Oct 23, 2025 • Finanz und Wirtschaft
Transcript : Galderma Group AG, Q3 2025 Sales/ Trading Statement Call, Oct 23, 2025
Oct 23, 2025 • MarketScreener Schweiz
Galderma hebt Jahresprognose nach starken Quartalszahlen an und bekennt sich zu US-Expansion
Oct 23, 2025 • MarketScreener Deutschland
Galderma steigert Umsatz um 21 % in Q3 2025 und hebt Jahresprognose an
Oct 23, 2025 • Investing.com Deutsch
Galderma legt nach erfolgreichem dritten Quartal die Latte höher - Aktie legt deutlich zu
Oct 23, 2025 • cash.ch
Galderma Group AG hebt Gewinnprognose für das Gesamtjahr 2025 an
Oct 23, 2025 • MarketScreener Schweiz
Galderma überrascht mit guten Zahlen und Prognoseerhöhung
Oct 23, 2025 • Finanz und Wirtschaft
Galderma setzt Ziele erneut höher
Oct 23, 2025 • Cash
Galderma steigert Nettoumsatz in den ersten neun Monaten um 15 % gegenüber Vorjahr bei konstanten Wechselkursen
Oct 23, 2025 • MarketScreener Deutschland
Interview mit Thomas Dittrich - CFO Galderma Group AG​
Oct 22, 2025 • Deloitte
Weniger Risiken: Vontobel ist zuversichtlicher für Galderma
Oct 6, 2025 • Cash
Galderma-Aktie auf grünem Terrain: Neue Daten zu Ästhetik-Portfolio für Schönheitskongress angekündigt
Sep 24, 2025 • Finanzen.ch
Galderma kündigt Daten zu Ästhetik-Portfolio für Schönheitskongress an
Sep 24, 2025 • Cash
Galderma to present post-marketing data from ARTIST study on its Restylane hyaluronic acid injectables portfolio
Sep 24, 2025 • MarketScreener
Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education
Sep 24, 2025 • MarketScreener
AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education
Sep 24, 2025 • Morningstar.com
SMG’s muted IPO pop should guide H&F on Verisure pricing – ECM Pulse EMEA
Sep 23, 2025 • ION Analytics
Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period (2025-2034) Due to Breakthrough Therapies in Atopic Dermatitis, Asthma, CRSwNP, and Others | DelveInsight
Sep 22, 2025 • PR Newswire UK
Skin Boosters Market Size to Reach USD 3.25 Billion by 2032 Owing to the Surging Non-Invasive Aesthetic Treatments Demand Globally | S&S Insider
Sep 22, 2025 • SNS Insider pvt ltd
Galderma-Aktie tiefer: Galderma startet neue Hautpflegelinie Skin Activator Hydrating & Firming
Sep 18, 2025 • Finanzen.ch
Galderma startet neue Hautpflegelinie Skin Activator Hydrating & Firming
Sep 18, 2025 • Cash
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partne...
Sep 18, 2025 • AETOSWire
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay
Sep 18, 2025 • thecanadianpressnews.ca
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay
Sep 18, 2025 • Morningstar.com
Galderma zeigt in Studie Auswirkungen des Lebensstils auf empfindliche Haut
Sep 17, 2025 • Cash
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin
Sep 17, 2025 • Morningstar.com
Is the Urban Jungle Wrecking Our Faces? Galderma Science Says Yes
Sep 17, 2025 • Global Cosmetic Industry Magazine
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin
Sep 17, 2025 • AETOSWire
Dermal Filler Market to Reach $10.97 Billion by 2029 with 11.1 CAGR
Sep 16, 2025 • EIN Presswire
L’Oréal downgraded by Jefferies, PT cut to €340 as growth outlook weakens
Sep 16, 2025 • Investing.com
Neue Website AKNEPORTAL.DE von Galderma unterstützt Jugendliche und Erwachsene, die mit Akne leben
Sep 15, 2025 • Presseportal
Galderma-Aktie stabil: Galderma stellt an Kongress neue Studiendaten vor
Sep 11, 2025 • Finanzen.ch
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
Sep 11, 2025 • thecanadianpressnews.ca
Galderma Brings Alastin® Skincare to China Amid Booming Aesthetics Market
Sep 11, 2025 • Global Cosmetics News
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
Sep 11, 2025 • Morningstar.com
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
Sep 11, 2025 • PharmiWeb
Galderma Announces the Launch of Four Core Alastin Products in China
Sep 10, 2025 • MarketScreener
Galderma launches Alastin in China
Sep 10, 2025 • MarketScreener
Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market
Sep 9, 2025 • Morningstar.com
SMG leads Europe’s IPO window but Stada sale pivot reveals barriers – ECM Pulse EMEA
Sep 9, 2025 • ION Analytics
Aktie von Sonova fällt aus dem SMI - Galderma neu im SLI - So reagieren die Aktien
Sep 8, 2025 • Finanzen.ch
Sponsor giants prep for final listed sell-downs of 2025 as window reopens – ECM Pulse EMEA
Sep 2, 2025 • ION Analytics
US IPO Week Ahead: IPO calendar prepares for post-Labor Day launches
Aug 29, 2025 • Renaissance Capital
Hyperpigmentation Treatment Market Size to Hit USD 2.36 Billion by 2032, Fueled by Growing Demand for Advanced Dermatological Therapies and Aesthetic Procedures – SNS Insider
Aug 27, 2025 • SNS Insider pvt ltd
Elizabeth Stanford Recognized by Influential Women 2025
Aug 26, 2025 • EIN Presswire
Evolus Announces Positive Data From Pivotal Trial for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp
Aug 25, 2025 • BioSpace
Galderma introduces Cetaphil Nourishing Oil to Foam Cleanser, a breakthrough in hydrating cleansing for sensitive skin
Aug 25, 2025 • PR Newswire
Evolus Announces Positive Data From Pivotal Trial for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp
Aug 25, 2025 • Business Wire
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product
Aug 20, 2025 • Business Wire
Facial Injectables Market Set to Surge: Revolutionary Treatments and Rising Consumer Demand Drive Growth in 2025
Aug 20, 2025 • EIN Presswire
Experte sieht nächstes Blockbuster-Produkt bei Galderma - und schraubt das Kursziel hoch
Aug 19, 2025 • Cash
Facial Injectables Market Set to Surge: Revolutionary Treatments and Rising Consumer Demand Drive Growth in 2025
Aug 19, 2025 • EIN Presswire
Global Botulinum Toxins Market to Surge to USD 15.7 Billion by 2030 | MarketsandMarkets™.
Aug 14, 2025 • MarketsandMarkets Research Pvt. Ltd.
For everyone with sensitive skin: Understanding skin science with Cetaphil and its new innovative product
Aug 12, 2025 • prnasia.com
Non-Surgical Aesthetic Device Market is Projected to Reach USD 6.5 Billion, with a Robust 5.4% CAGR Till 2035
Aug 12, 2025 • EIN Presswire
Energy-Based Aesthetic Devices Market Poised to Growth 24.21 USD Billion by 204 with Thriving CAGR of 9.58%
Aug 8, 2025 • EIN Presswire
Dermatology Device Market Projected to Hit USD 57.3 Billion by 2035, at a Exceptional CAGR 5.59%
Aug 6, 2025 • EIN Presswire
Lease roundup: Lefferts lands steakhouse at North Beach condo tower, Swiss skin care giant plans Brickell HQ
Aug 5, 2025 • The Real Deal
China Anti-acne Cosmetics Market Analysis Report and Growth Forecasts 2025-2030 | Local Manufacturers Lead with Innovations in Anti-acne Skincare Solutions
Aug 4, 2025 • Research and Markets
EQT Affiliate Completes Placement of Galderma Shares
Aug 1, 2025 • MarketScreener
EQT completes sale of shares in skincare company Galderma
Aug 1, 2025 • PE Hub
Global Skin Cancer Treatment Market Size to Reach USD 19.27 Billion by 2032, Driven by Rising Melanoma Cases and Advancements in Immunotherapy | SNS Insider
Jul 31, 2025 • SNS Insider pvt ltd
Consortium Sells 7.1% of Galderma Share Capital in CHF 2.1 Billion Placement
Jul 30, 2025 • globallegalchronicle.com
Galderma: EQT und Partner verkaufen Aktien für 2,1 Mrd. Fr.
Jul 29, 2025 • Finanz und Wirtschaft
Dermatological Drugs Market Forecast to 2034 – For Business Leaders, Analysts, and Strategic Teams
Jul 29, 2025 • EIN Presswire
Galderma Group Erstes Halbjahr 2025 Ergebnisse: Erwartungen übertroffen
Jul 28, 2025 • simplywall.st
Galderma Reports Record H1 Sales of US$2.45 Billion, Raises 2025 Guidance on Blockbuster Growth
Jul 28, 2025 • Global Cosmetics News
U.S. Aesthetic Injectable Market Size, Share & Trends Analysis Report 2018-2024 & 2025-2030 | Minimally Invasive Demand, Youth Adoption, and Product Innovation Fuel Aesthetic Market Growth
Jul 25, 2025 • Research and Markets
Galderma mit starkem erstem Semester - Umsatzziele werden angehoben
Jul 24, 2025 • Cash
Galderma Delivers Record First Half 2025 Net Sales of 2.448 Billion USD and 12.2% Year-on-Year Growth at Constant Currency, Raises Full-Year Top-Line Guidance
Jul 24, 2025 • BioSpace
Botulinum Toxin Market to Reach USD 13.1 Billion, Globally, by 2031 at 8.6% CAGR: Allied Market Research
Jul 24, 2025 • EIN Presswire
Galderma Delivers Record First Half 2025 Net Sales of 2.448 Billion USD and 12.2% Year-on-Year Growth at Constant Currency, Raises Full-Year Top-Line Guidance
Jul 24, 2025 • UAE Business Review
Galderma at record high after FY sales outlook hike, H1 beat
Jul 24, 2025 • Reuters
Galderma Delivers Record First Half 2025 Net Sales of 2.448 Billion USD and 12.2% Year-on-Year Growth at Constant Currency, Raises Full-Year Top-Line Guidance
Jul 23, 2025 • Morningstar.com
Botulinum Toxin Market to grow with rising anti-aging demand and aesthetic use at 10% CAGR by 2030
Jul 21, 2025 • PharmiWeb
Cosmetic Surgery Market Outlook (2024-2035): Trends, Growth, and Future Projections
Jul 18, 2025 • PharmiWeb
Galderma erzielt Studienerfolg bei Behandlung von Patienten nach Gewichtsverlust
Jul 17, 2025 • Cash
Galderma Unveils Final Nine-Month Data Showing Lasting Efficacy and Patient Satisfaction With Its Injectable Aesthetics...
Jul 17, 2025 • AETOSWire
Galderma's Sculptra-Restylane Regimen Sustains Facial Aesthetic Improvement in Phase 4 Study
Jul 17, 2025 • MarketScreener
Von Dr. Wolff zu Galderma
Jul 16, 2025 • Apotheke Adhoc
Galderma: Ist der Dermatologiespezialist ein Übernahmekandidat?
Jul 8, 2025 • Cash

Links

www.galderma.comLinkedInX (Twitter)Crunchbase